A new degree program in applied AI at the largest art and design school in the U.S. has prompted varied reactions from ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...

FIG trades at premium valuations with strong margins and an AI-driven platform, but slowing growth and insider selling raise ...

At 101 years young Methven's Audrey Lilley has embarked on an ambitious fundraiser to help the Methven Care Trust develop a purpose-built care home facility and increase the number of elderly it can ...